New techniques are increasingly effective, but we don't yet know how to combine different treatments in a tailored, ...

who may choose to consider other approved therapies or first-line clinical trials. Such differentiation is key in optimizing treatment strategies, potentially leading to improved patient outcomes, ...

Credit: Getty Images Clinicians can use 4 key questions to initiate discussions about pelvic health, aiding in screening, and determining the need for pelvic health physical therapy or further ...

In some cases, doctors can’t be completely sure it’s CIDP, but they may go ahead and start treatment. If the symptoms improve, that’s strong evidence it’s CIDP. Early treatment is key.

These data suggest that adagrasib monotherapy may represent a viable first-line treatment option for this specific patient subgroup, particularly in the absence of KEAP1 comutations, especially for ...

This is the first exosome-based therapy in Korea to enter clinical trials, marking a major milestone in the country's biopharmaceutical landscape. S&E bio developed SNE-101 using a proprietary 3D ...

Norwegian Cruise Line Holdings reported financial results for the first quarter ended March 31, 2025 and provided guidance for the second quarter and full year 2025. “We kicked off 2025 with solid ...

These data suggest that adagrasib monotherapy may represent a viable first-line treatment option for this specific patient subgroup, particularly in the absence of KEAP1 comutations, especially for ...

Analysis of nearly 21,000 psychiatric inpatients in Beijing from 2005 to 2018 shows a significant rise in type 2 diabetes mellitus (T2DM) among those with depression, with 9.13% affected.

Bayer has launched a first-in-human clinical trial for 225Ac-GPC3 (BAY 3547926), a novel targeted alpha radiopharmaceutical for advanced hepatocellular carcinoma. The therapy uses a GPC3-targeting ...